Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Net Cash Flow (2021 - 2025)

Prime Medicine filings provide 5 years of Net Cash Flow readings, the most recent being -$8.4 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 112.97% to -$8.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$119.8 million, a 184.69% decrease, with the full-year FY2025 number at -$119.8 million, down 184.69% from a year prior.
  • Net Cash Flow hit -$8.4 million in Q4 2025 for Prime Medicine, down from $17.6 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $139.7 million in Q4 2022 to a low of -$90.6 million in Q1 2025.
  • Median Net Cash Flow over the past 5 years was -$12.9 million (2023), compared with a mean of -$7.3 million.
  • Biggest five-year swings in Net Cash Flow: surged 6691.46% in 2022 and later tumbled 272.28% in 2025.
  • Prime Medicine's Net Cash Flow stood at -$2.1 million in 2021, then surged by 6691.46% to $139.7 million in 2022, then plummeted by 101.71% to -$2.4 million in 2023, then soared by 2804.36% to $64.5 million in 2024, then crashed by 112.97% to -$8.4 million in 2025.
  • The last three reported values for Net Cash Flow were -$8.4 million (Q4 2025), $17.6 million (Q3 2025), and -$38.4 million (Q2 2025) per Business Quant data.